Park Place Capital Corp Viking Therapeutics, Inc. Put Options Transaction History
Park Place Capital Corp
- $323 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VKTX
# of Institutions
433Shares Held
65.2MCall Options Held
8.28MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$272 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$161 Million0.01% of portfolio
-
State Street Corp Boston, MA4.06MShares$108 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY3.13MShares$83.6 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.12MShares$83.5 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.05B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...